The legality of President Trump’s exemptions for certain polluters is under scrutiny as a coalition of environmental groups has filed a lawsuit challenging these exemptions in the U.S. District Court for the District of Columbia. The litigation comes in response to a controversial policy introduced last spring by the Environmental Protection Agency (EPA), which suggested that companies could request exemptions from specific Clean Air Act regulations, particularly those affecting emissions of ethylene oxide, a known carcinogen.
In March 2024, the EPA announced that companies could submit requests for exemptions via a designated email address. This initiative attracted responses from hundreds of businesses, including coal plants and chemical manufacturers. Among the most prominent voices seeking exemption were medical device sterilizers, with approximately 40 of the 90 such facilities in the United States submitting applications. These sterilizers argued that they should not be bound by air quality regulations limiting toxic emissions, given their reliance on ethylene oxide for sterilizing medical equipment.
In a significant policy shift, the Biden administration had previously mandated that these sterilizers reduce their emissions by around 90 percent by the end of 2024. This requirement prompted many facilities to begin investing in new pollution control technologies. Following Trump’s inauguration, however, the EPA allowed these companies to seek presidential exemptions, which were granted through a proclamation last summer.
One of the key plaintiffs in the lawsuit is Maurice Carter, president of the Georgia-based environmental advocacy group Sustainable Newton. He emphasized that financial interests should not eclipse public health concerns related to ethylene oxide emissions. “You have to do that in ways that are not harmful to the people that live here and to the planet that our children are going to inherit,” Carter stated, highlighting his proximity to one of the exempted facilities.
The case has been assigned to Judge Christopher R. Cooper, who was appointed by former President Obama. Trump’s Justice Department, which represents federal agencies in court, has 60 days to respond to the lawsuit. A spokesperson for the White House defended the exemptions, asserting that the president acted within his lawful authority under the Clean Air Act to provide relief for facilities vital to the supply of medical equipment.
According to the EPA, the Clean Air Act allows the president to grant limited exemptions if meeting the standards would not be feasible due to technology limitations and if the exemption serves the national interest. The industry’s trade organization, the Ethylene Oxide Sterilization Association, contended in a letter that workforce shortages and supply chain issues made it impossible for sterilizers to meet the 2024 emissions rule within the required timeframes.
When the EPA finalized the emissions rule, it found that only seven out of 88 sterilization facilities had already complied with the new standards. Approximately 30 facilities were required to install advanced pollution control technologies known as Permanent Total Enclosures, which can significantly increase operational costs. Notably, Georgia has the highest concentration of exempt sterilization plants, with all five facilities in the state receiving exemptions. In contrast, only two of California’s facilities, which lead the nation in sterilization operations, were exempted, as most already met the new standards.
Critics argue that the exemptions undermine ongoing compliance efforts. Sarah Buckley, a senior attorney with the Natural Resources Defense Council, expressed concern that the exemptions appear to be arbitrary. “These are facilities that have been making changes to their processes in their facilities to comply, and yet they received exemptions anyway,” Buckley noted, describing the exemptions as a “get-out-of-jail-free card.”
Environmental advocates worry that the exemptions will allow companies to bypass compliance costs and responsibilities. The EPA has estimated that achieving the new standards would cost about $313 million for all sterilization facilities. Companies that receive exemptions may avoid significant expenses associated with maintaining monitoring and pollution control equipment, raising questions about the fairness of the policy.
The lawsuit represents a broader challenge to the Trump administration’s approach to environmental regulations. Last year, Trump issued numerous exemptions for over 150 facilities across various industries, including coal and chemical manufacturing, prompting several legal challenges from environmental groups.
As the legal proceedings unfold, the implications of these exemptions could have lasting effects on air quality and public health in communities near these facilities. The outcome of the lawsuit may shape future regulatory approaches and the balance between industrial interests and environmental protections.
